A systematic review of antidepressants in neuropathic pain

Pain

Volumn 68, Issue 2-3, 1996, Pages 217-227

  McQuay, H J ^a,c   Tramer M ^a   Nye, B A ^a   Carroll, D ^a   Wiffen, P J ^b   Moore, R A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b Pharmacy Department   (United Kingdom)

^c Pain Relief Unit   (United Kingdom)

Author keywords

antidepressants; neuropathic pain; systematic review

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DOSULEPIN; FLUOXETINE; FLUPHENAZINE; IMIPRAMINE; LORAZEPAM; MAPROTILINE; MIANSERIN; NORTRIPTYLINE; PAROXETINE;

ANALGESIA; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; HUMAN; NEUROPATHY; PAIN; PRIORITY JOURNAL; SIDE EFFECT;

ANTIDEPRESSIVE AGENTS; CHRONIC DISEASE; DIABETIC NEUROPATHIES; FACIAL PAIN; HUMANS; NEURALGIA; ODDS RATIO; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 0030443813     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(96)03140-5     Document Type: Article

References (38)

1. Cook, R.J. and Sackett, D.L., The number needed to treat: a clinically useful measure of treatment effect, Br. Med. J., 310 (1995) 452-454.
2. Davidoff, G., Guarracini, M., Roth, E., Sliwa, J. and Yarkony, G., Trazodone hydrochloride in the treatment of dysesthetic pain in traumatic myelopathy: a randomised, double-blind, placebo-controlled study, Pain, 29 (1987) 151-161.
3. Feinmann, C., Psychogenic facial pain: presentation and treatment, J.. Psychosom. Res., 27 (1983) 403-410.
4. Feinmann, C. and Harris, M., Psychogenic facial pain, part 2: management and prognosis, Br. Dent. J., 156 (1984) 205-208.
5. Feinmann, C., Harris, M. and Cawley, R., Psychogenic facial pain: presentation and treatment, Br. Med. J., 288 (1984) 436-438.
6. Gardner, M.J. and Altman, D.G., Statistics with Confidence, British Medical Journal, London, 1989.
7. Gomez-Perez, F.J., Rull, J.A., Dies, H., Rodriquez-Rivera, J.G., Gonzalez-Barranco, J. and Lozano-Castaneda, O., Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy: a double blind cross over study, Pain, 23 (1985) 395-400.
8. Jadad, A.R. and McQuay, H.J., A high-yield strategy to identify randomized controlled trials for systematic reviews, Online J. Curr. Clin. Trials [serial online], 33 (1993).
9. Jadad, A.R., Moore, R.A., Carroll, D., Jenkinson, C., Reynolds, D.J.M., Gavaghan, D.J. and McQuay, H.J., Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clin. Trials, 17 (1996) 1-12.
10. Kishore-Kumar, R., Max, M.B., Schafer, S.C., Gaughan, A.M., Smoller, B., Gracely, R.H. and Dubner, R., Desipramine relieves postherpetic neuralgia, Clin. Pharmacol. Ther., 47 (1990) 305-312.
11. Kvinesdal, B., Molin, J., Froland, A. and Gram, L.F., Imipramin ved behandling af smerter ved diabetisk ekstremitetsneuropati, Ugeskr. Laeg., 145 (1983) 3018-3019.
12. Kvinesdal, B., Molin, D., Froland, A. and Gram, L.A., Imipramine therapy of painful diabetic neuropathy, J. Am. Med. Assoc., 251 (1984) 1727-1730.
13. Langohr, H.D., Stöhr, M. and Petruch, F., An open and double blind cross over study on the efficacy of clomipramine (Anafranil) in patients with painful mono- and polyneuropathies, Eur. Neurol., 21 (1982) 309-317.
14. Lascelles, R.G., Atypical face pain and depression, Br. J. Psychiatry, 112 (1966) 651-659.
15. Leijon, G. and Boivie, J., Central post-stroke pain: a controlled trial of amitriptyline and carbamazepine, Pain, 36 (1989) 27-36.
16. Max, M.B., Culnane, M., Schafer, S.C., Gracely, R.H., Walther, D.J., Smoller, B. and Dubner, R., Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood, Neurology, 37 (1987) 589-596.
17. Max, M.B., Schafer, S.C., Culnane, M., Smoller, B., Dubner, R. and Gracely, R.H., Amitriptyline, but not lorazepam, relieves postherpetic neuralgia, Neurology, 38 (1988) 1427-1432.
18. Max, M.B., Kishore-Kumar, R., Schafer, S.C., Meister, B., Gracely, R.H., Smoller, B. and Dubner, R., Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial, Pain, 45 (1991) 3-9.
19. Max, M.B., Lynch, S.A., Muir, J., Shoaf, S.F., Smoller, B. and Dubner, R.. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy, N. Engl. J. Med., 326 (1992) 1250-1256.
20. McQuay, H.J., Carroll, D. and Glynn, C.J., Low dose amitriptyline in the treatment of chronic pain. Anaesthesia, 47 (1992) 646-652.
21. McQuay, H., Carroll, D., Jadad, A.R., Wiffen, P. and Moore, A., Anticonvulsant drugs for management of pain: a systematic review, Br. Med. J., 311 (1995) 1047-1052.
22. Mendel, C.M., Klein, R.F., Chappell, D.A., Dere, W.H., Gertz, B.J., Karam, J.H., Lavin, T.N. and Grunfeld, C., A trial of amitriptyline and fluphenazine in the treatment of painful diabetic neuropathy, J. Am. Med. Assoc., 255 (1986) 637-639.
23. Onghena, P. and Van Houdenhove, B., Antidepressant-induced analgesia in chronic nonmalignant pain: a meta-analysis of 39 placebo-controlled studies, Pain, 49 (1992) 205-219.
24. Panerai, A.E., Monza, G., Movilia, P., Bianchi, M., Francucci, B.M. and Tiengo, M., A randomized, within patient, cross over, placebo controlled trial on the efficacy and tolerability of the tricyclic antidepressants chlorimipramine and nortriptyline in central pain, Acta Neurol. Scand., 82 (1990) 34-38.
25. Sharav, Y., Singer, E., Schmidt, E., Dionne, R.A. and Dubner, R., The analgesic effect of amitriptyline on chronic facial pain, Pain, 31 (1987) 199-209.
26. Sindrup, S.H., Ejlertsen, B., Frøland, A., Sindrup, E.H., Brøsen, K. and Gram, L.F., Imipramine treatment in diabetic neuropathy: relief of subjective symptoms without changes in peripheral and autonomic nerve function, Eur. J. Clin. Pharmacol., 37 (1989) 151-153.
27. Sindrup, S.H., Gram, L.F., Brosen, K., Eshoj, O. and Mogensen, E.F., The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain, 42 (1990a) 135-144.
28. Sindrup, S.H., Gram, L.F., Skjold, T., Frøland, A. and Beck-Nielsen, H., Concentration-response relationship in imipramine treatment of diabetic neuropathy symptoms, Clin. Pharmacol. Ther., 47 (1990b) 509-515.
29. Sindrup, S.H., Gram, L.F., Skjold, T., Grodum, E., Brøsen, K. and Beck-Nielsen, H., Clomipramine vs. desipramine vs. placebo in the treatment of diabetic neuropathy symptoms: a double-blind cross-over study, Br. J. Clin. Pharmacol., 30 (1990c) 683-691.
30. Sindrup, S.H., Bach, F.W. and Gram, L.F., Plasma beta-endorphin is not affected by treatment with imipramine or paroxetine in patients with diabetic neuropathy symptoms, Clin. J. Pain, 8 (1992a) 145-148.
31. Sindrup, S.H., Bjerre, U., Dejgaard, A., Brøsen, K., Aaes-Jørgensen, T. and Gram, L.F., The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy, Clin. Pharmacol. Ther., 52 (1992b) 547-552.
32. Sindrup, S.H., Tuxen, C., Gram, L.F., Grodum, E., Skjold, T., Brøsen, K. and Beck-Nielsen, H., Lack of effect of mianserin on the symptoms of diabetic neuropathy, Eur. J. Clin. Pharmacol., 43 (1992c) 251-255.
33. Spilker, B., Guide to Clinical Trials, Raven Press, New York, 1991, pp. 699-700.
34. Stockstill, J.W., McCall, W.D., Jr., Gross, A.J. and Piniewski, B., The effect of L-tryptophan supplementation and dietary instruction on chronic myofascial pain, J. Am. Dent. Assoc., 118 (1989) 457-460.
35. Turkington, R.W., Depression masquerading as diabetic neuropathy, J. Am. Med. Assoc., 243 (1980) 1147-1150.
36. Watson, C.P., Evans, R.J., Reed, K., Merskey, H., Goldsmith, L. and Warsh, J., Amitriptyline versus placebo in postherpetic neuralgia, Neurology, 32 (1982) 671-673.
37. Watson, C.P., Chipman, M., Reed, K., Evans, R.J. and Birkett, N., Amitriptyline versus maprotiline in postherpetic neuralgia: a randomized, double-blind, crossover trial, Pain, 48 (1992) 29-36.
38. Young, R.J. and Clarke, B.F., Pain relief in diabetic neuropathy: the effectiveness of imipramine and related drugs, Diabetic Med., 2 (1985) 363-366.